A red-shifted fluorescent substrate for aldehyde dehydrogenase, AldeRed 588-A, for labeling viable ALDH-positive cancer stem cells

被引：0
|
作者：
Asbrock, N. J. [1 ]
Chu, V. [1 ]
Taganov, K. [1 ]
Pomper, M. [2 ]
机构：
[1] EMD Millipore, Temecula, CA USA
[2] Johns Hopkins, Baltimore, MD USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1145
引用
收藏
页数：1
相关论文
共 7 条
  • [1] A red-shifted fluorescent substrate for aldehyde dehydrogenase, AldeRed 588-A, for labeling viable ALDH-positive cells
    Asbrock, Nick
    Chu, Vi
    Romper, Martin
    CANCER RESEARCH, 2016, 76
  • [2] A red-shifted fluorescent substrate for aldehyde dehydrogenase, AldeRed 588-A, for labeling viable ALDH-positive cells
    Chu, Vi
    Taganov, Konstantin
    Ramesh, D.
    Asbrock, Nick
    Pomper, Martin
    CANCER RESEARCH, 2015, 75
  • [3] A red-shifted fluorescent substrate for aldehyde dehydrogenase
    Il Minn
    Haofan Wang
    Ronnie C. Mease
    Youngjoo Byun
    Xing Yang
    Julia Wang
    Steven D. Leach
    Martin G. Pomper
    Nature Communications, 5
  • [4] A red-shifted fluorescent substrate for aldehyde dehydrogenase
    Minn, Il
    Wang, Haofan
    Mease, Ronnie C.
    Byun, Youngjoo
    Yang, Xing
    Wang, Julia
    Leach, Steven D.
    Pomper, Martin G.
    NATURE COMMUNICATIONS, 2014, 5
  • [5] ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays
    Jin Won Park
    Kyung-Ho Jung
    Youngjoo Byun
    Jin Hee Lee
    Seung Hwan Moon
    Young Seok Cho
    Kyung-Han Lee
    Scientific Reports, 9
  • [6] ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays
    Park, Jin Won
    Jun, Kyung-Ho
    Byun, Youngjoo
    Lee, Jin Hee
    Moon, Seung Hwan
    Cho, Young Seok
    Lee, Kyung-Han
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
    Ruscito, Ilary
    Castillo-Tong, Dan Cacsire
    Vergote, Ignace
    Ignat, Iulia
    Stanske, Mandy
    Vanderstichele, Adriaan
    Ganapathi, Ram N.
    Glajzer, Jacek
    Kulbe, Hagen
    Trillsch, Fabian
    Mustea, Alexander
    Kreuzinger, Caroline
    Panici, Pierluigi Benedetti
    Gourley, Charlie
    Gabra, Hani
    Kessler, Mirjana
    Sehouli, Jalid
    Darb-Esfahani, Silvia
    Braicu, Elena Ioana
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 214 - 225
1